Letters to the Editor

Short-course subcutaneous alemtuzumab induces clinical responses in relapsed T-cell large granular leukemia

Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
Center for Biostatistics, Department of Biomedical Informatics, The Ohio State University, Columbus, OH
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology and Department of Cancer Biology, Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
Division of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Department of Medical Oncology and Department of Cancer Biology, Sydney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
Haematologica Early view Nov 14, 2024 https://doi.org/10.3324/haematol.2024.286235